First, gain-of-function and loss-of-function experiments should be conducted on SASH1 in HNSCC cells and animal models using CRISPR/Cas9 gene-editing technology to directly verify its effects on tumor proliferation, invasion, and matrix remodeling. Here, SASH1 is linked to head and neck squamous cell carcinoma.